Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $104,710 | 67 | 68.9% |
| Consulting Fee | $23,440 | 25 | 15.4% |
| Food and Beverage | $19,837 | 1,009 | 13.1% |
| Travel and Lodging | $3,876 | 27 | 2.6% |
| Education | $8.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $46,004 | 355 | $0 (2024) |
| Allergan, Inc. | $33,047 | 68 | $0 (2022) |
| Amgen Inc. | $21,912 | 62 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $12,064 | 51 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $10,191 | 48 | $0 (2021) |
| Lilly USA, LLC | $5,926 | 40 | $0 (2024) |
| Lundbeck LLC | $5,734 | 42 | $0 (2024) |
| Promius Pharma LLC | $4,356 | 10 | $0 (2019) |
| Biohaven Pharmaceutical Holding Company Ltd. | $4,098 | 56 | $0 (2022) |
| Depomed, Inc. | $2,609 | 13 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,045 | 186 | ABBVIE INC. ($7,756) |
| 2023 | $7,723 | 153 | ABBVIE INC. ($6,450) |
| 2022 | $13,916 | 208 | ABBVIE INC. ($8,982) |
| 2021 | $43,036 | 156 | AbbVie Inc. ($22,816) |
| 2020 | $24,690 | 95 | Allergan, Inc. ($16,125) |
| 2019 | $17,524 | 135 | Teva Pharmaceuticals USA, Inc. ($7,979) |
| 2018 | $25,577 | 106 | Amgen Inc. ($14,899) |
| 2017 | $10,360 | 90 | Allergan Inc. ($6,418) |
All Payment Transactions
1,129 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: PAIN | ||||||
| 12/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $2.11 | General |
| Category: PAIN | ||||||
| 12/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: PAIN | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $38.54 | General |
| Category: Neurology | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Neurology | ||||||
| 12/08/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $0.78 | General |
| Category: Neurology | ||||||
| 12/06/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: PAIN | ||||||
| 12/04/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: Immune | ||||||
| 12/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/22/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Neuroscience | ||||||
| 11/21/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $31.81 | General |
| Category: Rare Disease | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $21.92 | General |
| Category: NEUROLOGY | ||||||
| 11/18/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $16.86 | General |
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: PAIN | ||||||
| 11/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.32 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/11/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Neuroscience | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: PAIN | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $0.56 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 542 | 31,767 | $967,277 | $223,546 |
| 2022 | 12 | 533 | 29,637 | $899,498 | $207,646 |
| 2021 | 13 | 485 | 30,582 | $880,020 | $204,417 |
| 2020 | 11 | 408 | 27,975 | $621,238 | $178,916 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 98 | 31,200 | $674,870 | $151,100 | 22.4% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 88 | 168 | $97,121 | $21,258 | 21.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 37 | 37 | $49,832 | $13,026 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 90 | $31,527 | $9,180 | 29.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 89 | 96 | $33,183 | $8,293 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 80 | $19,876 | $5,671 | 28.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 31 | 31 | $18,896 | $4,623 | 24.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 22 | 22 | $16,119 | $4,080 | 25.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 16 | 16 | $13,626 | $3,266 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $12,228 | $3,050 | 24.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 92 | 29,100 | $633,507 | $139,896 | 22.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 83 | 156 | $90,057 | $19,996 | 22.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 82 | 91 | $31,459 | $8,279 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $27,161 | $7,711 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 64 | $22,420 | $6,689 | 29.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 19 | 20 | $24,573 | $6,478 | 26.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 28 | 28 | $17,112 | $4,489 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 56 | $13,906 | $3,919 | 28.2% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 14 | 14 | $11,923 | $3,139 | 26.3% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 17 | 17 | $12,480 | $3,098 | 24.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 16 | $7,857 | $2,107 | 26.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 15 | 15 | $7,043 | $1,845 | 26.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 89 | 30,065 | $635,634 | $142,398 | 22.4% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 84 | 165 | $93,364 | $21,120 | 22.6% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 65 | 72 | $24,767 | $6,614 | 26.7% |
About Dr. Emily Engel, M.D
Dr. Emily Engel, M.D is a Neurology healthcare provider based in La Jolla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093787038.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emily Engel, M.D has received a total of $151,871 in payments from pharmaceutical and medical device companies, with $9,045 received in 2024. These payments were reported across 1,129 transactions from 57 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($104,710).
As a Medicare-enrolled provider, Engel has provided services to 1,968 Medicare beneficiaries, totaling 119,961 services with total Medicare billing of $814,525. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location La Jolla, CA
- Active Since 02/03/2006
- Last Updated 01/13/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1093787038
Products in Payments
- UBRELVY (Drug) $59,144
- NURTEC ODT (Drug) $14,823
- Aimovig (Biological) $14,328
- BOTOX (Biological) $10,268
- AJOVY (Drug) $8,060
- QULIPTA (Drug) $6,005
- VYEPTI (Biological) $5,651
- Zembrace (Drug) $4,333
- AJOVY (Biological) $3,894
- Otezla (Drug) $3,865
- BOTOX CHRONIC MIGRAINE (Drug) $3,068
- Cambia (Drug) $2,607
- APTIOM (Drug) $620.61
- EMGALITY (Drug) $548.15
- TROKENDI XR (Drug) $461.27
- KESIMPTA (Drug) $434.53
- SPRIX (Drug) $398.81
- AIMOVIG (Biological) $237.78
- INGREZZA (Drug) $172.28
- Briviact (Drug) $161.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in La Jolla
Charles Smith, M.d, M.D
Neurology — Payments: $590,505
Dr. Jody Corey-Bloom, Md, Phd, MD, PHD
Neurology — Payments: $452,305
Dr. Jay Rosenberg, M.d, M.D
Neurology — Payments: $216,627
Dr. Christy Jackson, M.d, M.D
Neurology — Payments: $213,127
Dr. Dee Silver, Md, MD
Neurology — Payments: $103,830
Dr. Douglas Galasko, Md, MD
Neurology — Payments: $76,399